1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Facts of premise;

A. B around March 31, 2009, between the Plaintiff and the Plaintiff, as the insured B, attached Form B, which is a lost medical insurance.

1. The written insurance contract (hereinafter referred to as the “instant insurance contract, etc.”) was concluded, and the major contents of the relevant renewed medical expenses guarantee agreement are attached hereto;

2. The description;

B. B underwent a surgery on May 30, 2014, on the two upper scopic scopic scopic scopic scopic scopic scopic scopic scopic scopica, etc., but underwent a surgery and a radioactive therapy on several occasions due to a recurrence or transition, and underwent a copic scopic scopic scopic around September 2016.

C. B received hospital hospitalization treatment in relation to the above species (hereinafter “instant disease”) from October 12, 2016 to December 6, 2016. The competent physician provided F medical treatment and diagnosed “the same as the combined organization of the abnormal population and the peltos of the peltos of the peltos of the peltos of the peltos of the peltos of the peltos of the peltos.”

F medical treatment means a homicide cell (Cykine-inced kine-inced cll, CIK) that destroys the cykine cells without a source of resistance by means of the treatment of cata-cella celbing sather sather sather sather celfeced sat.

Cytoxic Tymphocyte (Cytoxic Tymphocyte) that destroys cancer cells with recognition of port source presented. It is an immune cell therapy whose principal ingredient is.

E. B received the above hospitalized treatment, and claimed the Plaintiff the amount of the Defendant’s reimbursement and the amount of the reimbursement under the National Health Insurance Act. Of the claimed amount, the F medical expenses included KRW 23,650,00 (=4,730,000 each time = 4,730,000).

F. The Plaintiff, not subject to the terms and conditions, refused to pay F medical treatment costs, and the Defendants were the inheritors of B (hereinafter “the deceased”) who died during the instant lawsuit (hereinafter “the deceased”). The statutory inheritance share is Defendant C3/7, Defendant D, and E 2/7.

[Ground of recognition] Facts without dispute, Gap 1-3, 8 evidence, Eul 1, 3, 38, 39 evidence, and objection.